We’re eager to share more news: Quest Diagnostics® has integrated Haystack MRD® ctDNA testing and Comprehensive Genomic Profiling into the OncoEMR® electronic health record system through their Molecular Profiling Integration (MPI) feature. All providers in the OncoEMR network will have access to these advanced tests in the second half of the year.
This announcement from Quest Diagnostics underscores our goal to bring advanced testing directly and seamlessly into the clinical workflow, regardless of the EHR platform you use.
Read the press release here.
